Literature DB >> 29957478

CSF miR-16 expression and its association with miR-16 and serotonin transporter in the raphe of a rat model of depression.

Qiong-Yan Shao1, Fei You2, Yong-Hua Zhang1, Lin-Lin Hu3, Wen-Juan Liu3, Yi Liu3, Jing Li3, Sheng-Dong Wang3, Ming-Fen Song4.   

Abstract

BACKGROUND: Depression is a common mental disorder with unknown mechanism. Emerging evidence shows that miRNAs play a critical role in the process of depression. Here we reported the cerebrospinal fluid (CSF) miR-16 expression and its association with miR-16 and serotonin transporter (SERT) in the raphe of a rat model of depression.
METHODS: 20 rats were randomized to the control or CUMS (chronic unpredictable mild stress) group. The rats in the CUMS group underwent CUMS for 21 days, while those in the control group received no treatment. After anesthetization, CSF was collected for the measurement of miR-16. Then raphes from all rats were separated for determination of miR-16 and SERT protein.
RESULTS: The expression levels of miR-16 in CSF and raphe of the CUMS group were significantly lower than those of the control group (P = 0.007 and 0.031). However, SERT protein in raphe of the CUMS group was obviously increased as compared that of the control group (P = 0.005). There was a positive correlation between CSF miR-16 and raphe miR-16 (r = 0.95, P = 0.000). Meanwhile, negative correlations between miR-16 and SERT protein in raphe (r = -0.70 P = 0.02), between CSF miR-16 and raphe SERT protein (r = -0.86, P = 0.002) were observed in the CUMS group. LIMITATIONS: We have not explored the reason why CSF miR-16 was decreased in the rat model of depression and only tested the association of miR-16 between CSF and raphe.
CONCLUSIONS: CSF miR-16 was involved in the pathogenesis of depression via reflecting raphe miR-16 level, and thus affecting raphe SERT expression.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Chronic unpredictable mild stress; Depression; Serotonin transporter; miR-16

Mesh:

Substances:

Year:  2018        PMID: 29957478     DOI: 10.1016/j.jad.2018.06.034

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  5 in total

Review 1.  The important roles of microRNAs in depression: new research progress and future prospects.

Authors:  Chenggui Miao; Jun Chang
Journal:  J Mol Med (Berl)       Date:  2021-02-27       Impact factor: 4.599

2.  Construction and dissection of the ceRNA‑ceRNA network reveals critical modules in depression.

Authors:  Yan Lang; Jingchao Zhang; Zheng Yuan
Journal:  Mol Med Rep       Date:  2019-03-05       Impact factor: 2.952

3.  Optimization of food deprivation and sucrose preference test in SD rat model undergoing chronic unpredictable mild stress.

Authors:  Li-Wen He; Li Zeng; Na Tian; Yi Li; Tong He; Dong-Mei Tan; Qian Zhang; Yi Tan
Journal:  Animal Model Exp Med       Date:  2020-03-31

4.  Prognostic plasma exosomal microRNA biomarkers in patients with substance use disorders presenting comorbid with anxiety and depression.

Authors:  Fengrong Chen; Lei Zou; Yicong Dai; Jiaxue Sun; Cheng Chen; Yongjin Zhang; Qingyan Peng; Zunyue Zhang; Zhenrong Xie; Hongjin Wu; Weiwei Tian; Xu Yu; Juehua Yu; Kunhua Wang
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

5.  Inhibition of miR-16 enhances the sensitivity of fibroblast-like synovial cells to methotrexate by restraining MDR1/P-gp expression via NF-κB pathway.

Authors:  Jing Wang; Ni Mao; Yiming Liu; Xi Xie; Jing Tian; Fen Li; Jinwei Chen
Journal:  RSC Adv       Date:  2019-08-27       Impact factor: 4.036

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.